Effects of amitriptyline, amitriptylinoxide, doxepine and clozapine on N-methyl-D-aspartate-evoked release of [3H]-acetylcholine in rat caudatoputamen

Arzneimittel-Forschung/Drug Research

Volumn 49, Issue 10, 1999, Pages 820-823

  Kiefer, Gerrit ^a   Fischer, Wilhelm ^b   Feuerstein, Thomas J ^a,c  

^a Neurozentrum   (Germany)

^b Klinische Forschung Asthma and Allergie   (Germany)

^c Neurozentrum   (Germany)

Author keywords

Acetylcholine; Amitriptyline; Amitriptylinoxide; Cholinergic interneuron; Clozapine; Doxepine; N Methyl D aspartate receptor; Rat; Release

Indexed keywords

ACETYLCHOLINE; AMITRIPTYLINE; AMITRIPTYLINOXIDE; CLOZAPINE; DOXEPIN; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEUROLEPTIC AGENT; TRICYCLIC ANTIDEPRESSANT AGENT;

ACETYLCHOLINE RELEASE; ANALGESIC ACTIVITY; ANIMAL TISSUE; ARTICLE; BRAIN SLICE; COMPETITIVE INHIBITION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; DRUG POTENCY; MALE; NERVE CONDUCTION; NONHUMAN; PUTAMEN; RAT; SPINAL CORD DORSAL HORN;

EID: 0032721079     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0031-1300508     Document Type: Article

References (23)

1. [1] Seeman, P., Neuropsychopharmacology 7, 261 (1992)
2. [2] Eisenach, J. C., Gebhart, G. F., Anesthesiology 83, 1046 (1995)
3. [3] Nankai, M., Fage, D., Carter, C., J. Neurochem. 64, 2043 (1995)
4. [4] Watanabe, Y., Saito, H., Abe, K., Neuropharmacology 32, 479 (1993)
5. [5] Dickenson, A. H., Acta Anaesthesiol. Scand. 1997 41, 112 (1997)
6. [6] Kawamata, M., Omote, K., Pain 68, 85 (1996)
7. [7] Carlsson, M., Carlsson, A., Trends Neurosci. 13, 272 (1990)
8. [8] Richardson, I. W., Szerb, J. C., Br. J. Pharmacol. 52, 499 (1974)
9. [9] Darstein, M., Löschmann, P. A. Knörle, R., Naunyn Schmiedeberg's Arch. Pharmacol. 356, 738 (1997)
10. [10] Feuerstein, T. J., Sauermann, W., Allgaier, C., Naunyn-Schmiedebergs Arch. Pharmacol. 347, 171 (1993)
11. [11] Gardner, M. J., Altman, D. G., Br. Med. J. (Clin. Res. Ed.) 292, 746 (1986)
12. [12] Darstein, M., Albrecht, C., Lópes-Francos, L., Alcohol Clin. Exp. Res. 22 (3), 704 (1998)
13. [13] Feuerstein, T. J., Anaesthesist 43 (Suppl. 2), 48 (1994)
14. [14] Lehmann, J., Scatton, B., Brain Res. 252 (I), 77 (1982)
15. [15] Lupp, A., Lücking, C. H., Koch, R., J. Pharmacol. Exp. Ther. 263, 717 (1992)
16. [16] Jackisch, R., Kruchen, A., Hertting, G., Eur. J. Pharmacol. 264 (2), 207 (1994)
17. [17] Agneter, E., Singer, E. A., Sauermann, W., Naunyn Schmiedeberg's Arch. Pharmacol. 356, 283 (1997)
18. [18] Feuerstein, T. J., Limberger, N., Naunyn-Schmiedeberg's Arch. Pharmacol. 359, 349 (1999)
19. [19] Koch, H., Isr. J. Psychiatry. Relat. Sci. 27, 48 (1990)
20. [20] Verghese, C., Kessel, J. B., Simpson, G. M., Psychopharmacol. Bull. 27, 551 (1991)
21. [21] Dickenson, A. H., Br. J. Anaesth. 75, 193 (1995)
22. [22] Liu, H. T., Manyth, P. W., Basbaum, A. I., Nature 386 721 (1997)
23. [23] Feuerstein, T. J., Schmerz 11, 213 (1997)